Update to the national guideline of the Canadian Research Initiative in Substance Matters for the clinical management of opioid use disorder

This guideline lays out the optimal strategies for the treatment of opioid addiction and recommends opioid agonist treatment with buprenorphine-naloxone as the preferred first-line treatment.